Davinci Laboratories

Multi-Source Cal Mag

D
N+ Score61
Joint & BoneServing: 3 Tablet(s)Type: Other Combinations

Davinci Laboratories Multi-Source Cal Mag is a bone health supplement containing 4 ingredients. It features Calcium at 450mg and Magnesium at 450mg, both of which are present at clinically studied dosages, potentially supporting bone density and muscle function. However, the Vitamin D3 content is underdosed compared to research-backed levels. This product holds an N+ Score of 61, earning a 'D' grade, indicating an average formulation with room for improvement in ingredient adequacy and completeness, despite 100% label transparency. It may be suitable for individuals seeking foundational calcium and magnesium support, though additional Vitamin D supplementation might be considered.

About This Product

Multi-Source Cal Mag by Davinci Laboratories is a joint & bone supplement containing 4 active ingredients. It has earned an N+ Score of 61/100 (Grade D).

Notable clinical-dose ingredients include Calcium, Magnesium.

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity86/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +2 ingredient(s) at clinical dose levels

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (4 ingredients)

IngredientAmountDose Adequacy
Calcium450.000 mgAdequate
Magnesium450.000 mgHigh
Betaine Hydrochloride75.000 mgN/A
Vitamin D31.900 mcgUnder

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.